Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |